Cargando…
Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
Background: This study aims to analyse whether in acute heart failure (AHF) with iron deficiency (ID), the administration of ferric carboxymaltose (FCM) produces a greater benefit in renal dysfunction. Methods: A total of 812 consecutive patients admitted for AHF and ID were studied. Untreated (n:27...
Autores principales: | López-Vilella, Raquel, Guerrero Cervera, Borja, Donoso Trenado, Víctor, Sánchez-Lázaro, Ignacio, Martínez Dolz, Luis, Almenar Bonet, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144873/ https://www.ncbi.nlm.nih.gov/pubmed/37109444 http://dx.doi.org/10.3390/life13040915 |
Ejemplares similares
-
Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study
por: López-Vilella, Raquel, et al.
Publicado: (2022) -
Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment
por: López‐Vilella, Raquel, et al.
Publicado: (2023) -
COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods
por: Donoso Trenado, Víctor, et al.
Publicado: (2022) -
COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital
por: López-Vilella, Raquel, et al.
Publicado: (2021) -
The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions
por: López-Vilella, Raquel, et al.
Publicado: (2021)